We are live on ! Find out more
PULM icon

Pulmatrix

5 hedge funds and large institutions have $116K invested in Pulmatrix in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

0% more funds holding

Funds holding: 55 (0)

27% less capital invested

Capital invested by funds: $158K → $116K (-$42K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$73K +$36.3K +17 +68%
WA
2
WFG Advisors
Texas
$35K
TRCT
3
Tower Research Capital (TRC)
New York
$4K
UBS Group
4
UBS Group
Switzerland
$4K +$6.4K +3 New
BRWA
5
B. Riley Wealth Advisors
Florida
$6 +$8.53K +4 New
TDC
6
Thompson Davis & Co
Virginia
-$39K -16 Closed
Bank of America
7
Bank of America
North Carolina
-$1K
Citigroup
8
Citigroup
New York
-$1K

PULM Hedge Fund Activity: Q4 2014 in Review

5 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Pulmatrix (PULM) for Q4 2014, worth a combined $116K — down 27% from $158K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PULM positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $36.3K. The largest seller was Thompson Davis & Co, exiting entirely with an estimated $39K sold.

  • 5 institutional investors held Pulmatrix (PULM) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $116K of Pulmatrix stock for Q4 2014, down 27% quarter-over-quarter.
  • 2 funds opened new Pulmatrix positions in Q4 2014 and 1 closed out, a net change of +1 holder.
  • The largest Pulmatrix buyer in Q4 2014 was Morgan Stanley, an estimated $36.3K added.
  • The largest Pulmatrix seller in Q4 2014 was Thompson Davis & Co, an estimated $39K sold.

Based on aggregated 13F filings for Q4 2014.